Initiation, adherence to AIs low for older women with DCIS

(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 in Cancer.

Factors associated with adherence to medications for lowering breast cancer risk between female Medicare beneficiaries in Alabama and nationwide

PDF) Tamoxifen Initiation After Ductal Carcinoma In Situ

Disparities Archives - Kaiser Permanente Division of Research

Older Patients With Low-Risk DCIS May Not Benefit From Surgery, Radiation

PDF) Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study

JBC :: Journal of Breast Cancer

Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review - ScienceDirect

Full article: Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study

Breast Cancer

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality